Leva, Giacomo
 Distribuzione geografica
Continente #
EU - Europa 98
NA - Nord America 82
AS - Asia 78
SA - Sud America 6
AF - Africa 1
OC - Oceania 1
Totale 266
Nazione #
US - Stati Uniti d'America 80
IT - Italia 40
SG - Singapore 25
CN - Cina 17
RU - Federazione Russa 14
HK - Hong Kong 13
FR - Francia 10
AT - Austria 8
BR - Brasile 6
DE - Germania 6
IN - India 6
GB - Regno Unito 4
PK - Pakistan 4
VN - Vietnam 4
NL - Olanda 3
SE - Svezia 3
BE - Belgio 2
CA - Canada 2
FI - Finlandia 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
LV - Lettonia 2
DZ - Algeria 1
ES - Italia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TR - Turchia 1
TW - Taiwan 1
Totale 266
Città #
Urbino 19
Singapore 18
Ashburn 16
Dallas 14
Hong Kong 13
Los Angeles 10
Ancona 8
Beijing 8
Vienna 8
Rome 7
New York 6
Paris 6
Boardman 4
Moscow 4
Denver 3
Nuremberg 3
Ahmedabad 2
Amman 2
Amsterdam 2
Città Sant'Angelo 2
Kochi 2
Lahore 2
Lauterbourg 2
New Haven 2
Rawalpindi 2
Riga 2
Sundbyberg 2
Tokyo 2
Varaždin 2
Ankara 1
Atlanta 1
Auckland 1
Baba Hassen 1
Boa Nova 1
Boston 1
Brussels 1
Buffalo 1
Cagliari 1
Calgary 1
Canary Wharf 1
Chennai 1
Chicago 1
Columbus 1
Des Moines 1
East District 1
Florence 1
Florianópolis 1
Frankfurt am Main 1
Glasgow 1
Guarulhos 1
Hangzhou 1
Harrisburg 1
Helsinki 1
Ho Chi Minh City 1
Kuala Selangor 1
Lanzhou 1
Leuven 1
London 1
Montreal 1
Mumbai 1
Orem 1
Perm 1
Phoenix 1
Poplar 1
Qingdao 1
Quảng Ngãi 1
Quận Năm 1
Redondo Beach 1
Rio Grande 1
Russellville 1
Salt Lake City 1
San Francisco 1
Santa Rita do Novo Destino 1
Shenzhen 1
Stockholm 1
São Paulo 1
Turku 1
Warsaw 1
Yangzhou 1
Totale 223
Nome #
KRAS-mutated patients with liver-only metastatic colorectal cancer treated with Bevacizumab and chemotherapy. Functional analysis of TP53 mutations and outcomes 136
Expression of circulating KRAS-4a and KRAS-4b mRNA isoforms in Patients with metastatic lung adenocarcinoma treated with Pembrolizumab or chemotherapy plus Pembrolizumab by liquid biopsy. Clinical impact and assoociation with circulating Pd-L1 97
Prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms in patients with metastatic lung adenocarcinoma treated with Pembrolizumab  23
Multicenter prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms (SNPs) in patients with metastatic lung adenocarcinoma (MLA) treated with pembrolizumab (P) 18
Totale 274
Categoria #
all - tutte 854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 4 10 0 2 0 2 0 1
2024/2025113 4 2 6 0 2 27 23 5 7 21 11 5
2025/2026142 17 10 25 21 66 3 0 0 0 0 0 0
Totale 274